IPO News

Lenskart IPO Opens on Oct 31: Price Band, GMP, and Key Details Investors Should Know

Lenskart IPO to Open on October 31: Price Band, GMP, and Subscription Details Revealed

India’s leading eyewear brand Lenskart Solutions Ltd is gearing up for its much-anticipated initial public offering (IPO), opening for public subscription on October 31, 2025, and closing on November 4, 2025. With the price band fixed between ₹382 and ₹402 per share, the ₹7,278-crore public issue has already created significant buzz among retail and institutional investors.

At the upper end of the price band, Lenskart is seeking a valuation exceeding ₹69,700 crore, positioning it among the largest new-age consumer tech listings in India’s market history. The bidding for anchor investors is set to open on October 30, a day before the public issue begins.

Lenskart IPO: Key Details and Offer Structure

The Lenskart IPO comprises both a fresh issue of shares and an offer for sale (OFS) by existing shareholders. According to the offer structure,

  • 75% of the issue is reserved for qualified institutional buyers (QIBs),

  • 15% for non-institutional investors (NIIs), and

  • 10% for retail investors.

The shares are expected to list on November 10, on both the BSE and NSE.

Founded in 2008 by Peyush Bansal, Lenskart started as an online eyewear platform in 2010 and has since evolved into a leading omnichannel retailer, with physical stores across metro, Tier-1, and Tier-2 cities in India, along with a growing footprint in Southeast Asia and the Middle East.

Lenskart IPO Valuation and Financial Performance

According to market analysts, Lenskart’s IPO valuation looks ambitious yet promising. At the upper price band of ₹402, the company’s valuation works out to 10.1x FY25 EV/Sales and 68.7x EV/EBITDA on a post-issue basis.

Analysts at SBI Securities noted that while the valuation appears stretched, the company’s scalable business model, strong brand recall, and the expanding domestic eyewear market offer long-term potential.

Lenskart has also shown notable improvement in profitability metrics over the past two years. The company’s EBITDA margin has increased from 7.0% in FY23 to 14.7% in FY25, reflecting operational efficiency and cost optimization.

Analysts advise investors to subscribe for the long term, particularly at the cut-off price, emphasizing that sustained profitability and market leadership will determine future returns.

Lenskart IPO GMP Today: Grey Market Premium Indicates Positive Sentiment

As of October 28, Lenskart’s IPO is witnessing strong interest in the grey market. According to data from Investorgain, the Lenskart IPO GMP (Grey Market Premium) stands at around ₹90 per share, implying a potential listing gain of over 22%.

This positive sentiment in the unlisted market suggests robust investor appetite ahead of the official subscription opening. Market experts, however, caution that GMP trends are subject to volatility and should not be the sole basis for investment decisions.

Business Overview: Lenskart’s Growth and Market Leadership

Lenskart has emerged as India’s largest organised retailer of prescription eyewear by B2C sales volume and is among the top two eyewear players in Asia. The company’s success lies in its technology-driven supply chain, AI-enabled virtual try-on tools, and direct-to-consumer business model, which help reduce costs and improve accessibility.

Over the past few years, Lenskart has diversified its offerings to include prescription glasses, sunglasses, contact lenses, and accessories, catering to both affordable and premium segments. Its strategic partnerships and acquisitions — including stakes in global eyewear brands — have further strengthened its global presence.

The company’s expansion into Southeast Asia and the Middle East has allowed it to tap into underpenetrated markets, driving steady growth in revenue and customer base.

Market Outlook: The Future of the Eyewear Industry

India’s eyewear industry is witnessing rapid transformation, driven by rising digital adoption, urbanization, and increasing health awareness. According to market reports, the domestic eyewear market is expected to grow at a CAGR of over 10% over the next five years.

As one of the few profitable consumer-tech startups, Lenskart’s scalable omnichannel model positions it well to capitalize on this expansion. The company continues to invest in AI-based lens manufacturing, supply chain automation, and international retail to strengthen its competitive advantage.

Should You Apply for the Lenskart IPO?

While Lenskart’s valuation appears premium, experts believe its long-term fundamentals remain strong. Investors looking for exposure to a high-growth, consumer-driven brand in the new-age retail segment may find the IPO worth considering.

However, those seeking short-term listing gains should be mindful of the stretched valuation and intense competition in the eyewear space. As always, experts recommend a balanced approach, with a focus on long-term growth potential rather than speculative gains.

Lenskart IPO Key Dates at a Glance

Event Date
IPO Open Date October 31, 2025
IPO Close Date November 4, 2025
Anchor Bidding Date October 30, 2025
Allotment Date November 8, 2025
Listing Date November 10, 2025

Sourabh Sharma

Sourabh loves writing about finance and market news. He has a good understanding of IPOs and enjoys covering the latest updates from the stock market. His goal is to share useful and easy-to-read news that helps readers stay informed.

Published by
Sourabh Sharma

Recent Posts

Rupee sinks to new record low at 90.56 against the US dollar

Rupee Extends Slide to Fresh All-Time Low as Trade Tensions and Importer Demand Intensify The…

14 hours ago

Sensex climbs 450 pts, Nifty ends near 26,050 as metal and realty stocks rally

Sensex Climbs 450 Points, Nifty Ends Near 26,050 as Global Cues Lift Market Sentiment Index…

15 hours ago

GIFT City to Host Edelweiss MF’s New Greater China Equity Product for Retail Investors

Edelweiss Mutual Fund Announces First International Retail Offering Through GIFT City Platform Edelweiss Mutual Fund…

16 hours ago

Cabinet set to clear Census 2027 and the Nuclear Energy Bill

Cabinet Meets to Consider Major Policy Overhaul Including Census 2027 and Key Sectoral Reforms The…

17 hours ago

Ozempic enters Indian market at Rs2,200 per week as Novo Nordisk expands diabetes portfolio

Novo Nordisk Brings Ozempic to India at Competitive Weekly Price to Expand Diabetes Treatment Access…

17 hours ago

ICICI Pru AMC IPO GMP Edges Higher on Strong Subscription Demand

ICICI Prudential AMC IPO GMP Rises as Investor Interest Builds Through the Session The grey…

18 hours ago

This website uses cookies.